Recent publications

• Strengthening Advocacy for Hepatitis C Diagnostics: Malaysia Workshop Summary Report

  

  1-3 March 2019, Penang, Malaysia
  Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More

  14 June 2019

• Strengthening Advocacy for Hepatitis C Diagnostics: Georgia Workshop Summary Report

  

  13-15 May 2019, Tbilisi, Georgia
  The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More

  10 July 2019

• Global Declaration to Eliminate Hepatitis C in People Who Use Drugs: A call for political leaders to take action

  

  Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More

  31 October 2018

• Updated Hepatitis C Treatment Guidelines

  

  Geneva - July 2018
  The World Health Organization released the updated Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. They follow and update the screening and care section of the WHO Guidelines for the screening, care and treatment of (...) More

  8 November 2018

• Hepatitis C among People who use drugs 61th CND Side Event (March 2018)

  

  On March 16th, during the 61th Session of the Commission on Narcotic Drugs (CND) held in Vienna (Austria), a side event untitled “Hepatits C among people who use drugs – the global state and recommendations” was sponsored by the World Health Organization (WHO), Norway government, the International (...) More

  9 April 2018